Medical Absolute Strategy

INSTITUTIONAL

INVESTMENT OBJECTIVE:

The Coronation Medical Absolute Strategy targets positive real returns with an overriding focus on limiting downside returns or portfolio losses. Therefore, capital preservation in real terms is equally important to return optimisation. The Strategy is managed in accordance with the limits of Annexure B of Regulation 30 of the Medical Schemes Act.


Coronation is a long-term, valuation-driven investment house. Our aim is to identify mispriced assets trading at discounts to their long-term business value (fair value) through extensive proprietary research. In calculating fair values, through our fundamental research, we focus on through-the-cycle normalised earnings and/or free cash flows using a long-term time horizon. The Portfolio is constructed on a cleanslate basis based on the relative risk-adjusted upside to fair value of each underlying security. The Portfolio is constructed with no reference to a benchmark. We do not equate risk with tracking error, or divergence from a benchmark, but rather with a permanent loss of capital.

Loading Chart Data...

The value of investments may go down as well as up, and is therefore not guaranteed. Past performance is not necessarily an indication of future performance.

CUMULATIVE PERFORMANCE
1 MONTH 1 YEAR 3 YEARS 5 YEARS SINCE INCEPTION
Strategy (0.2)% 6.5% 8.9% 8.5% 11.2%
Benchmark* 1.0% 5.6% 6.1% 5.1% 5.5%
Difference (1.2)% 0.9% 2.8% 3.4% 5.7%
CALENDAR YEAR PERFORMANCE
YEAR TO DATE 2023 2022 2021 2020
Strategy (0.3)% 11.1% 5.1% 15.9% 6.3%
Benchmark* 1.1% 5.1% 7.2% 5.9% 3.1%
Difference (1.4)% 5.9% (2.1)% 10.0% 3.2%

* Consumer Price Index (CPI)

The value of investments may go down as well as up, and is therefore not guaranteed. Past performance is not necessarily an indication of future performance.